How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial)

[1]  Gusto Angiographic Investigators.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[2]  A. Maseri,et al.  Age-Related Increase in Mortality among Patients with First Myocardial Infarctions Treated with Thrombolysis , 1993 .

[3]  P. Kudenchuk,et al.  Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project). , 1993, The American journal of cardiology.

[4]  M. Winniford,et al.  Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. , 1993, Journal of the American College of Cardiology.

[5]  Jeffrey L. Anderson,et al.  Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction , 1993 .

[6]  L. Wilkins.  Early Effects of Tissue‐Type Plasminogen Activator Added to Conventional Therapy on the Culprit Coronary Lesion in Patients Presenting With Ischemic Cardiac Pain at Rest Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trialx , 1993, Circulation.

[7]  R. Diaz,et al.  Significance of Smoking in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction Experience Gleaned From the International Tissue Plasminogen Activator/Streptokinase Mortality Trial , 1993, Circulation.

[8]  P. Mølstad.  First myocardial infarction in smokers. , 1991, European heart journal.

[9]  A. LaCroix,et al.  Smoking and mortality among older men and women in three communities. , 1991, The New England journal of medicine.

[10]  W. Rogers,et al.  Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.

[11]  H. White,et al.  Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking. , 1990, Journal of the American College of Cardiology.

[12]  A. Skene,et al.  Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study , 1990, The Lancet.

[13]  R. Gibbons,et al.  Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy. , 1989, Journal of the American College of Cardiology.

[14]  F. Werf.  DISCREPANCIES BETWEEN THE EFFECTS OF CORONARY REPERFUSION ON SURVIVAL AND LEFT VENTRICULAR FUNCTION , 1989, The Lancet.

[15]  R. Conroy,et al.  Smoking and acute coronary heart disease: a comparative study. , 1988, British heart journal.

[16]  N. Benowitz.  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. , 1988, The New England journal of medicine.

[17]  T. Meade,et al.  EFFECTS OF CHANGES IN SMOKING AND OTHER CHARACTERISTICS ON CLOTTING FACTORS AND THE RISK OF ISCHAEMIC HEART DISEASE , 1987, The Lancet.

[18]  R Roberts,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.

[19]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[20]  Harold T. Dodge,et al.  Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* , 1987 .

[21]  S. Shapiro,et al.  The risk of myocardial infarction after quitting smoking in men under 55 years of age. , 1985, The New England journal of medicine.

[22]  E. Gilpin,et al.  Smoking status at the time of acute myocardial infarction and subsequent prognosis. , 1985, American heart journal.

[23]  C. Kluft,et al.  Effect of Chronic Smoking on Fibrinolysis , 1985, Arteriosclerosis.

[24]  D. Ramsdale,et al.  Smoking and coronary artery disease assessed by routine coronary arteriography. , 1985, British medical journal.

[25]  R. Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[26]  P. Cryer,et al.  Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. , 1976, The New England journal of medicine.

[27]  J. Mackeith.  DISCHARGE OF VIOLENT PATIENTS , 1975, The Lancet.

[28]  J. Kostis,et al.  The effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. , 1972, American heart journal.

[29]  F. D. H. Hall.  St. Luke's Hostel , 1895 .